Research Finds New Drug Candidate to Prevent Lethal Lung Inflammation

Research Finds New Drug Candidate to Prevent Lethal Lung Inflammation
PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils/JCI Insight
|Updated:
Acute lung injury is inherently a life-threatening disorder which can lead to acute respiratory distress syndrome (ARDS), a common global cause of death due to COVID-19.

The consequence of acute lung injury, ARDS, can come from many causes, but the overaction of neutrophils is one of the prominent signs of it.